125 related articles for article (PubMed ID: 392484)
1. Modern aspects of testing azole antifungals.
Haller I
Postgrad Med J; 1979 Sep; 55(647):681-2. PubMed ID: 392484
[TBL] [Abstract][Full Text] [Related]
2. [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)].
Haller I
Mykosen; 1979 Dec; 22(12):423-30. PubMed ID: 396473
[No Abstract] [Full Text] [Related]
3. Medically important fungi respond to azole drugs: an update.
Zavrel M; White TC
Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
5. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
[TBL] [Abstract][Full Text] [Related]
6. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
7. [Biochemistry of azole derivatives and the problem of drug resistance].
Kerridge D; Parker S
Ann Dermatol Venereol; 1989; 116 Suppl 1():7-9. PubMed ID: 2688527
[No Abstract] [Full Text] [Related]
8. [In vitro susceptibility of vaginal isolates of Candida vs clotrimazole and nystatin].
Suárez VL; Fernández Andreu CM
Rev Cubana Med Trop; 2003; 55(3):138-45. PubMed ID: 15849917
[TBL] [Abstract][Full Text] [Related]
9. [Synergistic effect of azole antimycotics (clotrimazole and fluconazole) and natural substances].
Kuruc M; Čonková E
Ceska Slov Farm; 2017; 66(4):164-167. PubMed ID: 29351379
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of saperconazole (R 66 905) in vitro.
Odds FC
J Antimicrob Chemother; 1989 Oct; 24(4):533-7. PubMed ID: 2613602
[TBL] [Abstract][Full Text] [Related]
11. Extracellular phospholipase production of oral Candida albicans isolates from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimycotics.
Ellepola AN; Samaranayake LP; Khan ZU
Braz J Microbiol; 2016; 47(4):911-916. PubMed ID: 27522928
[TBL] [Abstract][Full Text] [Related]
12. Effect of azoles on the secretion of a Candida albicans metallopeptidase.
Imbert C; Imbert-Bouyer S; Kauffmann-Lacroix C; Daniault G; Rodier MH
Mycopathologia; 2006 Mar; 161(3):147-52. PubMed ID: 16482386
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of coronarin D against Candida albicans.
Kaomongkolgit R; Jamdee K; Wongnoi S; Chimnoi N; Techasakul S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):61-6. PubMed ID: 22727093
[TBL] [Abstract][Full Text] [Related]
14. Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis.
Cross EW; Park S; Perlin DS
Microb Drug Resist; 2000; 6(2):155-61. PubMed ID: 10990271
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
[TBL] [Abstract][Full Text] [Related]
16. Serum or bile affects the in vitro azole susceptibilities of Candida spp.
Nagi M; Tanabe K; Takano Y; Kikuchi K; Miyazaki Y; Niimi M
Jpn J Infect Dis; 2009 Jul; 62(4):306-8. PubMed ID: 19628912
[TBL] [Abstract][Full Text] [Related]
17. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
18. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents.
Wakabayashi H; Abe S; Okutomi T; Tansho S; Kawase K; Yamaguchi H
Microbiol Immunol; 1996; 40(11):821-5. PubMed ID: 8985937
[TBL] [Abstract][Full Text] [Related]
19. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]